Navigation Links
Newly Revised Concepts in Clinical Pharmacokinetics Web-Based Continuing Education Course Offered by the University of Georgia
Date:10/11/2010

Pharmacokinetics is a self-paced, self-study, online continuing pharmacy education program offering Interactive media to enhance a participant's learning experience. The comprehensive, state-of-the-art curriculum is divided into eleven modules and five Cases that include:

  1. Introduction to Pharmacokinetics
  2. Basic Pharmacokinetics
  3. Half-life, Elimination Rate Constant and AUC
  4. Intravenous Bolus Administration, Multiple Drug Administration, and Steady-State Average Concentrations
  5. Relationships of Pharmacokinetic Parameters and Intravenous Intermittent and Continuous Infusions
  6. Two-Compartment Models
  7. Biopharmaceutics: Absorption
  8. Drug Distribution and Protein Binding
  9. Drug Elimination Processes
  10. Nonlinear Processes
  11. Pharmacokinetic Variation and Model Independent Relationships

Five Cases (Available in Option #2 and Option #3)

  1. Aminoglycosides
  2. Vancomycin
  3. Theophylline
  4. Phenytoin
  5. Digoxin

The new course, based on the bestselling textbook of the same title, Concepts in Clinical Pharmacokinetics, 5th Edition, presented by the American Society of Health-System Pharmacists, is rich in multimedia elements that expand on the text and stimulate learning.

For more information on this program, visit www.georgiacenter.uga.edu/pharmacokinetics, or call Pam Bracken at +1-706-542-3537 or e-mail at Pam.Bracken@georgiacenter.uga.edu.

The University of Georgia Center for Continuing Education is a unit of the University of Georgia's Office of the Vice President for Public Service and Outreach. The Georgia Center provides innovative lifelong learning opportunities through its continuing education programs
'/>"/>

SOURCE University of Georgia
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Newly Re-launched Website Helps PhDs and MDs Capitalize on Growth in Life Science Industries
2. Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
3. Newly Published Data Demonstrate ASP EVOTECH® ECR Provides Cleaning That is Superior to Manual Cleaning of Flexible Endoscopes
4. Siemens Primed to Help Customers Achieve Newly-Defined Criteria for Meaningful Use of an Electronic Health Record
5. TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohns Disease
6. Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia
7. Newly Published Acetadote(R) Data Shows Product Can Provide Substantial Cost-Savings for Healthcare Systems
8. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the United States to Utilize Newly FDA-Cleared CARTO(R) 3 Navigation System
9. Newly Updated Pharmacy State Law Compendium Available
10. VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
11. Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... EVANSTON, Ill. , Nov. 21, 2014  Heated ... prescription drug prices – from cancer treatments to Gilead,s ... and pharmaceutical leaders around the world questioning what it ... quality of care. And while drug ... the pharmaceutical industry – from both a general business ...
(Date:11/21/2014)... Clementia Pharmaceuticals, Inc.  announced ... has granted Orphan Medicinal Product Designation for ... the treatment of fibrodysplasia ossificans progressiva (FOP). ... disease characterized by painful, recurrent episodes of ... bone formation. This process, known as heterotopic ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... Chief Executive Officer, will be presenting at the 26 th ... Palace Hotel in New York . The ... 2:00 PM ET. In addition, Mr. Krakauer and Jorgen ... separate one-on-one meetings during the day. An ...
Breaking Medicine Technology:"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3
... - IgG1 monoclonal,antibodies developed by ImClone Systems ... total presentations at the recently concluded,98th Annual ... Research,(AACR), including seven oral presentations and 37 ... the focus of,two back-to-back oral presentations leading ...
... ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abraxis ... discussed results from two pre-clinical studies ... and,rationale for combining nab-paclitaxel (ABRAXANE(R) for ... (albumin-bound)) with VEGF inhibitor drugs like,bevacizumab ...
Cached Medicine Technology:ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 2ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 3ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 4ImClone Systems Showcases Extensive Research and Development,Program at the AACR Annual Meeting 5Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5
(Date:11/21/2014)... CA (PRWEB) November 21, 2014 ... creating picture-perfect smiles for patients in preparation for the ... to the fronts of teeth, look completely natural, and ... certain situations, veneers are also valued for their ability ... patients and can be used on one or several ...
(Date:11/21/2014)... 2014 (HealthDay News) -- The cost of diabetes care ... recent years, climbing to more than $322 billion annually, ... cost were seen with prediabetes care, which have risen ... percent, the researchers added. In 2012, excess medical ... than $1,000 for every American. That total includes $244 ...
(Date:11/21/2014)... November 21, 2014 Richard Wolfe, ... , will present advanced benefits administration strategies during ... Houston HR Leadership Summit. This Game Changer breakout ... industry to present cutting-edge solutions and best practices ... explain how real-time data exchange between health and ...
(Date:11/21/2014)... Saint Luke’s Mid America Heart ... Failure Gold-Plus Quality Achievement Award for implementing specific ... Association/American College of Cardiology Foundation in their secondary ... With The Guidelines–Heart Failure is a quality improvement ... up-to-date, research-based guidelines with the goal of speeding ...
(Date:11/21/2014)... November 21, 2014 The typical Thanksgiving ... calorie dishes, plenty of gravy and a myriad of ... the best time of year to begin losing weight? ... has uncovered the secret to losing unhealthy, embarrassing and ... holiday recipes. , The insight to Diet Doc’s calorie ...
Breaking Medicine News(10 mins):Health News:Los Angeles Porcelain Veneers Dentist, Dr. Kevin Sands, Now Creates Picture-Perfect Smiles for Patients for the Holiday Season 2Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 2Health News:Empyrean Benefit Solutions CEO Sharing Latest Benefits Administration Strategies with Houston HR Leaders 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 2Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 3Health News:Diet Doc Releases New Calorie Loading Diet Plans - the Perfect Way to Jump Start the Metabolism and Begin Weight Loss During Thanksgiving 4
... in this group , WEDNESDAY, June 2 (HealthDay News) -- ... of developing prostate cancer than white men, but now a ... likely to develop aggressive forms of the disease. , Researchers ... whites -- whose prostates were removed at the Durham Veterans ...
... ... maker of the life’sDHA™ brand, Martek Biosciences Corporation (NASDAQ: MATK) announced today that Norman ... selected as the recipient of the Alex Leaf Distinguished Scientist Award for 2010. ... Columbia, Md. (Vocus) ...
... ... in the last several years. ,Global Launch Management, a product launch management company, offers ... traditional marketing, the product launch marketing model has been very successful for many 60 ... ...
... say , WEDNESDAY, June 2 (HealthDay News) -- A ... for a kind of brain tumor in children, researchers report. ... 20 percent of childhood brain cancer cases. Treatment, which can ... at five years to 70 percent, but the tumors remain ...
... donations have more than doubled since the institution of grassroots ... published in the May issue of the Journal of ... of minority donors is expected to reach 35 percent, up ... organ transplant in 1954, the shortage of organ donors has ...
... reporting new evidence that capsaicin, the stuff that gives chili ... buildup by triggering certain beneficial protein changes in the body. ... appears in ACS, monthly Journal of Proteome Research . ... obesity is a major public health threat worldwide, linked to ...
Cached Medicine News:Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 2Health News:Martek Biosciences Chief Scientific Officer, Dr. Norman Salem, 2010 Recipient of ,Alex Leaf Distinguished Scientist Award 3Health News:Traditional Marketing is Dead! GLM Creates a Sales Spike in Under 60 Days Stops Business Failure; Provides Startup Funding 2Health News:Grassroots programs to encourage minority organ donation prove successful 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: